Cargando…
Engineering receptors in the secretory pathway for orthogonal signalling control
Synthetic receptors targeted to the secretory pathway often fail to exhibit the expected activity due to post-translational modifications (PTMs) and/or improper folding. Here, we engineered synthetic receptors that reside in the cytoplasm, inside the endoplasmic reticulum (ER), or on the plasma memb...
Autores principales: | Mahameed, Mohamed, Wang, Pengli, Xue, Shuai, Fussenegger, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708828/ https://www.ncbi.nlm.nih.gov/pubmed/36446786 http://dx.doi.org/10.1038/s41467-022-35161-0 |
Ejemplares similares
-
Engineering a Rapid Insulin Release System Controlled By Oral Drug Administration
por: Mahameed, Mohamed, et al.
Publicado: (2022) -
Engineering autonomous closed-loop designer cells for disease therapy
por: Mahameed, Mohamed, et al.
Publicado: (2022) -
Phosphoregulated orthogonal signal transduction in mammalian cells
por: Scheller, Leo, et al.
Publicado: (2020) -
Engineering orthogonal signaling pathways reveals the sparse occupancy of sequence space
por: McClune, Conor J., et al.
Publicado: (2019) -
Modular control of multiple pathways using engineered orthogonal T7 polymerases
por: Temme, Karsten, et al.
Publicado: (2012)